|
Advertisements for Stimulant Drugs; Veterans of Iraq War and TBI; Chronic Inflammatory Demyelinating Polyneuropathy; Chronic Retinal Inflammation in MS Patients Today on Spotlight: The FDA has warned pharmaceutical companies about misleading information on advertisements for stimulant drugs. Veterans returning from the Iraq war have high rates of TBI and epilepsy. A new treatment has been approved for Chronic Inflammatory Demyelinating Polyneuropathy. Examination of retinas collected at autopsy of MS patients reveals progressive inflammation. Right click on the icon with the format of your choice (MP3 or Windows Media) and select "Save Target As..." or "Save Link As..." to download the file to your MP3 player or computer. Click on the grey arrow below to listen on your computer.  
File Size: 19.58 MB Playtime: 21:23 Subscribe directly using your preferred podcasting tool: 
Or, copy and paste this URL into a podcasting tool: 
Listen to this Podcast on your phone  Dial 1+ 510-495-6722
Long distance charges may apply
PREVIOUS PODCASTS
Pardupronox for PD; Mortality and Affluence; Pregabalin for Alcohol Withdrawal November 7, 2008 Pardupronox shows modest benefit and potentially advantageous side effect profile in the treatment of Parkinson's Disease. WHO statistics reflect decreased infectious disease but increased lifestyle-associated causes of mortality worldwide. The anticonvulsant pregabalin shows efficacy in reducing alcohol craving.
Veterans with ALS; Hemangiomas and PHACES; Alteplase for Stroke; OCD and Brain Abnormalities October 31, 2008 VA offers services to veterans with ALS. The location of hemangiomas correlates with anomalies in the neurocutaneous disorder PHACES. Alteplase may limit post-stroke morbidity. OCD patients and their relatives may share specific brain abnormalities. 
|